Press release
The US Compounding Pharmacies Market Analysis: $6.21 Billion Opportunities in the Next 6 Years - Arizton
According to Arizton's latest research report, the US compounding pharmacies market [https://www.arizton.com/market-reports/united-states-compounding-pharmacies-market] is growing at a CAGR of 4.06% during 2023-2029.Looking for More Information? Click:
[https://www.arizton.com/market-reports/united-states-compounding-pharmacies-market]
Report Scope:
Market Size (2029): $6.21 Billion
Market Size (2023): $4.89 Billion
CAGR (2023-2029): 4.06%
Historic Year: 2020-2022
Base Year: 2023
Forecast Year: 2024-2029
Market Segmentation: Product Type, Pharmacy Type, Sterility Type, Compounding Type, Application, Age Cohort
The US compounding pharmacy market occupies a unique position within the broader pharmaceutical industry, offering personalized medications tailored to individual patient needs. This market is driven by the rising demand for customized treatments, particularly for conditions not well-addressed by mass-produced drugs, such as allergies, unique dosage requirements, and specialized medical conditions. The aging population and an increasing prevalence of chronic diseases further fuel the market's growth, as compounded medications can provide alternative formulations, such as liquid or topical versions, for patients who cannot tolerate standard pills.
However, the market faces several challenges, including strict regulatory scrutiny. Compounding pharmacies must comply with both state and federal regulations, particularly after the 2012 fungal meningitis outbreak led to heightened oversight. The Drug Quality and Security Act (DQSA) created more stringent rules for larger operations, adding regulatory complexity. Additionally, smaller pharmacies struggle with the high costs of compliance and maintaining safety and quality standards, while competing with mass-produced pharmaceutical options.
Personalized Oral Medications Drive Growth in US Compounding Pharmacy Market
Oral compounded medications are a vital component of the US compounding pharmacy market, offering personalized solutions for patients when standard commercial medications are unsuitable. These custom medications address issues related to dosage, flavor, and form, improving patient compliance and therapeutic outcomes. Common oral product types include capsules, solutions and suspensions, troches and lozenges, and custom tablets, each tailored to meet specific patient needs, such as those requiring non-standard dosages, those with allergies, or patients who have difficulty swallowing pills.
These medications are crucial in personalized medicine, particularly for pediatric, geriatric, and allergy-sensitive patients. The ability to create customized dosages and remove allergens like gluten or lactose enhances treatment accessibility. Compounding pharmacies can also recreate discontinued medications. However, maintaining high-quality standards is essential, with pharmacies needing to follow strict protocols to ensure the accuracy, safety, and consistency of compounded oral products.
Market Opportunities
The collaboration between healthcare providers and compounding pharmacies drives personalized care
The US compounding pharmacy market is experiencing growth due to increasing collaboration with healthcare providers. This partnership enables the creation of customized medications that meet individual patient needs, particularly for those with allergies, unique dosage requirements, or specialized conditions. Compounding pharmacies help address drug shortages and discontinuations, ensuring continuity of care. Areas such as pain management, hormone therapy, and pediatric care are seeing significant benefits. Technological advances, including telehealth and e-prescriptions, enhance coordination and patient safety. As demand for personalized medicine rises, these collaborations are transforming treatment outcomes and expanding the scope of services in healthcare.
Competitive Overview
In the highly competitive US compounding pharmacy market, companies are adopting a range of strategies to differentiate themselves and drive growth. With the shift toward personalized medicine, compounding pharmacies are increasingly focusing on niche specialties to carve out unique positions in the healthcare landscape. Many are concentrating on specific therapeutic areas, such as bioidentical hormone replacement therapy (BHRT), pediatric formulations, and veterinary compounding, to address unmet needs not covered by traditional retail pharmacies or mass-produced medications.
To stay ahead, compounding pharmacies are also emphasizing high-quality standards, exceptional customer service, and technological innovation. This focus on quality assurance and advanced technologies helps improve patient outcomes and ensures compliance with stringent regulatory standards.
Sterile compounding, which involves the preparation of injectable medications or eye drops in sterile environments, is another key area of differentiation. Pharmacies excelling in sterile compounding cater to hospitals, clinics, and specialized medical centers, offering critical solutions that set them apart from other players in the market.
Vendor Insights
AVELLA SPECIALTY PHARMACY Avella Specialty Pharmacy enhances patient care with personalized compounded medications and invests in advanced compounding technologies.
CAPS CAPS strengthens partnerships with hospitals to provide sterile compounded medications, ensuring regulatory compliance and quality control.
FAGRON Fagron drives innovation in compounding by focusing on R&D and offering custom formulations, raw materials, and global expertise.
FRESENIUS KABI Fresenius Kabi specializes in compounded injectable medications and infusion solutions, prioritizing quality and safety in critical care.
PENCOL PHARMACY Pencol Pharmacy offers customized medication solutions with a patient-centric approach, ensuring compliance with regulatory standards.
Looking for More Information? Click:
https://www.arizton.com/market-reports/united-states-compounding-pharmacies-market
Key Company Profiles
* Avella Specialty Pharmacy
* CAPS
* Fagron
* Fresenius Kabi
* PenCol Pharmacy
* Austin Compounding Pharmacy
* Capstone Compounding Pharmacy
* Charles River Laboratories
* Dougherty's Pharmacy
* Eastern States Compounding Pharmacy
* Everwell Specialty Pharmacy
* Harrow
* Hill's Compounding Pharmacy and Milford Pharmacy
* INNOVATIVE RX
* Institutional Pharmacy Solutions
* ITC Compounding Pharmacy
* McGuff Company
* MediVera Compounding Pharmacy
* Nephron Pharmaceuticals
* PCCA
* Precision Compounding Pharmacy
* QuVa Pharma
* Sixth Avenue Medical Pharmacy
* St. Anthony Pharmacy
* The Compounding Pharmacy of America
* Triangle Compounding
* Valor Compounding Pharmacy
* Vertisis Custom Pharmacy
Market Segmentation
Product Type
* Oral
* Topical
* Parenteral
* Ophthalmic
* Others
Pharmacy Type
* 503A
* 503B
Sterility Type
* Sterile
* Non-sterile
Compounding Type
* Pharmaceutical Ingredient Alteration (PIA)
* Currently Unavailable Pharmaceutical Manufacturing (CUPM)
* Pharmaceutical Dosage Alteration (PDA)
Application
* Pain Management
* Hormone Replacement Therapy
* Anti-aging & Skin Care
* Nutritional Supplements
* Others
Age Cohort
* Adult
* Geriatric
* Pediatric
The Arizton Advisory & Intelligence market research report provides valuable market insights for industry stakeholders, investors, researchers, consultants, and business strategists aiming to gain a thorough understanding of the US compounding pharmacies market. Request for Free Sample to get a glance of the report now: https://www.arizton.com/market-reports/united-states-compounding-pharmacies-market
What Key Findings Our Research Analysis Reveals?
How big is the U.S. compounding pharmacies market?
What is the growth rate of the U.S. compounding pharmacies market?
What are the significant trends in the U.S. compounding pharmacies market?
Which compounding type segment dominates the U.S. compounding pharmacies market share?
Who are the key players in the U.S. compounding pharmacies market?
Looking for Customization According to Your Business Requirement? https://www.arizton.com/customize-report/4526
Other Related Reports that Might be of Your Business Requirement
Global Online Pharmacy Market - Focused Insights 2024-2029
https://www.arizton.com/market-reports/online-pharmacy-market-size-analysis
U.S. Pharmacy Benefit Management Market - Industry Outlook & Forecast 2024-2029
https://www.arizton.com/market-reports/pharmacy-benefit-management-market-in-united-states
Why Arizton?
100%Customer Satisfaction
24x7availability - we are always there when you need us
200+Fortune 500 Companies trust Arizton's report
80%of our reports are exclusive and first in the industry
100%more data and analysis
1500+reports published till date
Post-Purchase Benefit
* 1hr of free analyst discussion
* 10% off on customization
About Us:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=the-us-compounding-pharmacies-market-analysis-621-billion-opportunities-in-the-next-6-years-arizton]
Phone: +1 3122332770
Country: United States
Website: https://www.arizton.com/market-reports/united-states-compounding-pharmacies-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The US Compounding Pharmacies Market Analysis: $6.21 Billion Opportunities in the Next 6 Years - Arizton here
News-ID: 3762633 • Views: …
More Releases from ABNewswire
Phoenix Homeowners Continue Investing in Outdoor Spaces as Demand for Thoughtful …
MasterAZscapes LLC brings decades of landscape design and installation experience to meet the evolving needs of residential properties across Phoenix, Arizona.
As more homeowners seek functional and water-conscious outdoor living spaces, demand for Landscape Designer Phoenix [https://www.landscaper-phoenix.com/] services continues to grow throughout Phoenix AZ. Local landscaping trends increasingly emphasize sustainable designs, outdoor entertainment areas, and long-term property value. MasterAZscapes LLC [https://maps.app.goo.gl/v5awXgvdv45zV11o8], a Phoenix-based design-build landscaping company, has responded to these changing…
Growing Interest in Outdoor Living Spaces Fuels Demand for Custom Deck Projects …
GAB Construction supports homeowners with custom deck planning and construction as outdoor living investments continue to grow throughout the Renton region.
As homeowners continue investing in functional outdoor spaces, demand for Deck Builder Covington WA [https://gabconstructionam.com/covington-wa/] services has steadily increased throughout Renton WA and neighboring communities. Expanding outdoor living areas, replacing aging decks, and improving property value have become priorities for many residents. GAB Construction [https://maps.app.goo.gl/TVbMyg73rUzNY4va8], based in Renton, is helping…
Aurora Property Owners Turn to Professional Lawn Maintenance Solutions as Season …
NW Evergreen Landscape LLC supports Aurora homeowners with consistent lawn care services designed around Oregon's changing climate and outdoor maintenance demands.
As seasonal lawn challenges continue affecting residential properties, demand for Lawn Care in Aurora OR [https://nwevergreenlandscape.com/] services has grown among homeowners seeking dependable outdoor maintenance solutions. NW Evergreen Landscape LLC [https://maps.app.goo.gl/Dw6u9DfU1o1edXX59], located in Aurora, Oregon, has continued providing lawn and landscape care to help property owners maintain healthy outdoor environments.…
Saily Discount Code EDC10 Boosts eSIM Adoption in 2026
Saily Discount Code EDC10 helps travelers save on eSIM data plans worldwide. Discover the latest offer, trusted coverage, and partnership news for 2026.
Saily Discount Code EDC10 is now available for travelers seeking affordable mobile connectivity abroad, offering a 10% discount on eligible Saily eSIM data plans. The promotion is being highlighted through a new partnership between Saily and eSIMDiscount.codes, making it easier for consumers to access verified savings on one…
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
